Ignite Creation Date:
2025-12-24 @ 3:42 PM
Ignite Modification Date:
2026-07-21 @ 4:10 AM
Study NCT ID:
NCT01486992
Status:
UNKNOWN
Last Update Posted:
2012-01-12
First Post:
2011-11-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
mFOLFIRI Combine With Nimotuzumab Second Line Chemotherapy for Squamous-cell Carcinoma of the Esophagus
Sponsor:
Peking University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
N+FOLFIRI-AEC-4
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None